SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-428223
Filing Date
2014-11-28
Accepted
2014-11-28 16:06:01
Documents
8
Period of Report
2014-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d825616d8k.htm 8-K 20123
2 EX-4.1 d825616dex41.htm EX-4.1 493799
3 GRAPHIC g825616ex4_1pg053a.jpg GRAPHIC 2864
4 GRAPHIC g825616ex4_1pg053b.jpg GRAPHIC 3704
5 GRAPHIC g825616ex4_1pg055.jpg GRAPHIC 3587
6 GRAPHIC g825616ex4_1pg056.jpg GRAPHIC 3854
7 GRAPHIC g825616ex4_1pg057.jpg GRAPHIC 3221
8 GRAPHIC g825616ex4_1pg058.jpg GRAPHIC 4914
  Complete submission text file 0001193125-14-428223.txt   546792
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 141256004
SIC: 2834 Pharmaceutical Preparations